June 29, 2023 - 5:00 pm
June 29, 2023 - 6:00 pm
Global Implications: A Scalable Liquid Biopsy for HPV-related Cervical Cancer
Webinar hosted by Novosanis
Date: Thursday, June 29, 2023 11:00 ET / 17:00 CEST
Compared to invasive clinician-collected cervical scrapes or swabs, non-invasive first-void urine sampling may provide greater coverage of population screening for HPV-related cancers via a patient-preferred and less costly alternative. Invasive clinician-collected cervical scraping is the current gold standard in the US and other countries around the world for HPV-related cancer screening. However, patient access and adherence to HPV screening via clinician-collected samples are limited by factors such as geography, socioeconomic status, patient embarrassment, or patient discomfort. Along with patient barriers to HPV screening, invasive sampling is more costly than self-sampling as demonstrated in an economic evaluation of self-sampling and clinical-collected sampling by Aquarius Population Health.
Join Novosanis next webinar, moderated by Debra Fraser-Howze, Belinda Nedjai Ph.D. (Wolfson Institute of Population Health) and Elisabeth Adams Ph.D. (Aquarius Population Health) where they will present on a non-invasive-first-void urine sample collection as an alternative to clinician collected samples to reduce the cost of care and better support diversity, equity, and inclusion in healthcare.
- To discuss how non-invasive sample collection can support better diversity, equity and inclusion in healthcare
- To gain an appreciation for first void urine as an alternative to clinician-collected samples, including clinical research outcomes and patient preference indicators
- To understand the impact of self-collected FVU, as compared to clinician-collected samples, at geographic scale including the cost of care